302 related articles for article (PubMed ID: 32566684)
1. Animal Models of Diabetes-Associated Renal Injury.
Noshahr ZS; Salmani H; Khajavi Rad A; Sahebkar A
J Diabetes Res; 2020; 2020():9416419. PubMed ID: 32566684
[TBL] [Abstract][Full Text] [Related]
2. Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy.
Talukdar A; Basumatary M
Mol Biol Rep; 2023 Sep; 50(9):7759-7782. PubMed ID: 37458869
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
Shahni R; Gnudi L; King A; Jones P; Malik AN
Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
[TBL] [Abstract][Full Text] [Related]
4. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
5. Revisiting Experimental Models of Diabetic Nephropathy.
Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
[TBL] [Abstract][Full Text] [Related]
6. Rodent animal models: from mild to advanced stages of diabetic nephropathy.
Kaur M; Bedi O; Sachdeva S; Reddy BV; Kumar P
Inflammopharmacology; 2014 Oct; 22(5):279-93. PubMed ID: 25149089
[TBL] [Abstract][Full Text] [Related]
7. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
[TBL] [Abstract][Full Text] [Related]
8. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.
Takahashi T; Harris RC
J Diabetes Res; 2014; 2014():590541. PubMed ID: 25371905
[TBL] [Abstract][Full Text] [Related]
9. New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy.
Soler MJ; Riera M; Batlle D
Exp Diabetes Res; 2012; 2012():616313. PubMed ID: 22461787
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
[TBL] [Abstract][Full Text] [Related]
11. Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?
Nakhoul F; Nakhoul N; Asleh R; Miller-Lotan R; Levy AP
Diabetes Res Clin Pract; 2013 Jun; 100(3):289-97. PubMed ID: 23490597
[TBL] [Abstract][Full Text] [Related]
12. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
13. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
Zhao HJ; Wang S; Cheng H; Zhang MZ; Takahashi T; Fogo AB; Breyer MD; Harris RC
J Am Soc Nephrol; 2006 Oct; 17(10):2664-9. PubMed ID: 16971655
[TBL] [Abstract][Full Text] [Related]
15. Glypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney.
Okamoto K; Honda K; Doi K; Ishizu T; Katagiri D; Wada T; Tomita K; Ohtake T; Kaneko T; Kobayashi S; Nangaku M; Tokunaga K; Noiri E
Am J Pathol; 2015 Jul; 185(7):1889-98. PubMed ID: 25987249
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
[TBL] [Abstract][Full Text] [Related]
17. Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain.
Uil M; Scantlebery AML; Butter LM; Larsen PWB; de Boer OJ; Leemans JC; Florquin S; Roelofs JJTH
Sci Rep; 2018 Apr; 8(1):5542. PubMed ID: 29615804
[TBL] [Abstract][Full Text] [Related]
18. Acute Kidney Injury and Progression of Diabetic Kidney Disease.
Yu SM; Bonventre JV
Adv Chronic Kidney Dis; 2018 Mar; 25(2):166-180. PubMed ID: 29580581
[TBL] [Abstract][Full Text] [Related]
19. Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
Zhang J; Wang Y; Zhang R; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
Diabetes Res Clin Pract; 2018 Jul; 141():1-9. PubMed ID: 29684616
[TBL] [Abstract][Full Text] [Related]
20. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.
Yamakawa T; Kawaguchi T; Kitamura H; Kadomura M; Nishimura M; Yokoo T; Imasawa T
Clin Exp Nephrol; 2019 Apr; 23(4):521-529. PubMed ID: 30467801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
